Cocrystal Pharma appoints Carol L. Brosgart to board of directors

Cocrystal Pharma, Inc.

Carol L. Brosgart appointed as director effective August 12, 2026.
No arrangements or understandings with other persons regarding her selection.
No family relationships or related party transactions requiring disclosure.

item 5.02 item 9.01

Cocrystal Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-039023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.